Open-Label Study of Oral Treprostinil in Digital Ulcers
Public ClinicalTrials.gov record NCT00848107. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine: An Open-label Multicenter Extension Study
Study identification
- NCT ID
- NCT00848107
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- United Therapeutics
- Industry
- Enrollment
- 115 participants
Conditions and interventions
Conditions
Interventions
- treprostinil diethanolamine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2009
- Primary completion
- Aug 31, 2011
- Completion
- Aug 31, 2011
- Last update posted
- Jun 17, 2024
2009 – 2011
United States locations
- U.S. sites
- 22
- U.S. states
- 20
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama - Birmingham - Arthritis Clinical Intervention Program | Birmingham | Alabama | 35294-7201 | — |
| Mayo Clinic Scottsdale | Scottsdale | Arizona | 85259 | — |
| UCLA | Los Angeles | California | 90095-1670 | — |
| Barbara Davis Centre | Aurora | Colorado | 80045 | — |
| University of Connecticut Health Center | Farmington | Connecticut | 06030-1310 | — |
| Georgetown University - Dept. of Medicine/Rheumatology | Washington D.C. | District of Columbia | 20007 | — |
| Northwestern University - Feinberg School of Medicine | Chicago | Illinois | 60611 | — |
| Johns Hopkins University - Division of Rheumatology | Baltimore | Maryland | 21224 | — |
| Boston University School of Medicine | Boston | Massachusetts | 02118-2526 | — |
| University of Michigan - Scleroderma Program | Ann Arbor | Michigan | 48106 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| UMDNJ Clinical Research Center | New Brunswick | New Jersey | 08903 | — |
| North Shore - LIJ Health System | Lake Success | New York | 11042 | — |
| The Hospital for Special Surgery | New York | New York | 10021 | — |
| The Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| University of Toledo | Toledo | Ohio | 43614 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15261 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425-8900 | — |
| University of Texas - Houston | Houston | Texas | 77030 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
| Virginia Mason Medical | Seattle | Washington | 98101 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00848107, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 17, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00848107 live on ClinicalTrials.gov.